These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 37203393)

  • 1. Aprepitant inhibits the progression of esophageal squamous cancer by blocking the truncated neurokinin‑1 receptor.
    Zheng Y; Sang M; Liu F; Gu L; Li J; Wu Y; Shan B
    Oncol Rep; 2023 Jul; 50(1):. PubMed ID: 37203393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substance P accelerates the progression of human esophageal squamous cell carcinoma via MMP-2, MMP-9, VEGF-A, and VEGFR1 overexpression.
    Mohammadi F; Javid H; Afshari AR; Mashkani B; Hashemy SI
    Mol Biol Rep; 2020 Jun; 47(6):4263-4272. PubMed ID: 32436041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aprepitant Promotes Caspase-Dependent Apoptotic Cell Death and G2/M Arrest through PI3K/Akt/NF-
    Javid H; Afshari AR; Zahedi Avval F; Asadi J; Hashemy SI
    Biomed Res Int; 2021; 2021():8808214. PubMed ID: 34926694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of substance P/neurokinin 1 receptor in the pathogenesis of esophageal squamous cell carcinoma through constitutively active PI3K/Akt/NF-κB signal transduction pathways.
    Javid H; Asadi J; Zahedi Avval F; Afshari AR; Hashemy SI
    Mol Biol Rep; 2020 Mar; 47(3):2253-2263. PubMed ID: 32072401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SP promotes cell proliferation in esophageal squamous cell carcinoma through the NK1R/Hes1 axis.
    Wang F; Liu S; Liu J; Feng F; Guo Y; Zhang W; Zheng G; Wang Q; Cai L; Guo M; Lian X; Xu G; Zhang H
    Biochem Biophys Res Commun; 2019 Jul; 514(4):1210-1216. PubMed ID: 31109645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of fibulin-4 inhibits autophagy and promotes the sensitivity of esophageal squamous cell carcinoma cells to apatinib by activating the Akt-mTOR signaling pathway.
    Chen X; Wang J; Song L; Yu Y; Shi M; Jiang W; Liu X; He X
    Thorac Cancer; 2022 Sep; 13(18):2592-2605. PubMed ID: 35950373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of the Role of Neurokinin-1 Receptor Inhibition Using Aprepitant in the Apoptotic Cell Death through PI3K/Akt/NF-
    Ghahremanloo A; Javid H; Afshari AR; Hashemy SI
    Biomed Res Int; 2021; 2021():1383878. PubMed ID: 34395609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Knockdown of DEAD-box 51 inhibits tumor growth of esophageal squamous cell carcinoma
    Hu DX; Sun QF; Xu L; Lu HD; Zhang F; Li ZM; Zhang MY
    World J Gastroenterol; 2022 Jan; 28(4):464-478. PubMed ID: 35125830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homeobox D10, a tumor suppressor, inhibits the proliferation and migration of esophageal squamous cell carcinoma.
    Zhang J; Liu S; Zhang D; Ma Z; Sun L
    J Cell Biochem; 2019 Aug; 120(8):13717-13725. PubMed ID: 30938888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential in vitro therapeutic effects of targeting SP/NK1R system in cervical cancer.
    Mozafari M; Ebrahimi S; Darban RA; Hashemy SI
    Mol Biol Rep; 2022 Feb; 49(2):1067-1076. PubMed ID: 34766230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-derived exosomal hyaluronidase 1 induced M2 macrophage polarization and promoted esophageal cancer progression.
    Yuan J; Hou B; Guo K; Zhu J; Xiao H
    Exp Cell Res; 2024 Jun; 439(1):113963. PubMed ID: 38382806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hsa_circ_0023984 Regulates Cell Proliferation, Migration, and Invasion in Esophageal Squamous Cancer via Regulating miR-1294/PI3K/Akt/c-Myc Pathway.
    Liang W; Wang C; Wang J; Zhang M
    Appl Biochem Biotechnol; 2022 Sep; 194(9):1-16. PubMed ID: 35522362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SP/NK1R system regulates carcinogenesis in prostate cancer: Shedding light on the antitumoral function of aprepitant.
    Ebrahimi S; Mirzavi F; Aghaee-Bakhtiari SH; Hashemy SI
    Biochim Biophys Acta Mol Cell Res; 2022 May; 1869(5):119221. PubMed ID: 35134443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dandelion root extract affects ESCC progression
    Duan X; Pan L; Deng Y; Liu Y; Han X; Fu H; Li Y; Li M; Wang T
    Food Funct; 2021 Oct; 12(19):9486-9502. PubMed ID: 34476429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HERG1 promotes esophageal squamous cell carcinoma growth and metastasis through TXNDC5 by activating the PI3K/AKT pathway.
    Wang H; Yang X; Guo Y; Shui L; Li S; Bai Y; Liu Y; Zeng M; Xia J
    J Exp Clin Cancer Res; 2019 Jul; 38(1):324. PubMed ID: 31331361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatoblastoma cells express truncated neurokinin-1 receptor and can be growth inhibited by aprepitant in vitro and in vivo.
    Berger M; Neth O; Ilmer M; Garnier A; Salinas-Martín MV; de Agustín Asencio JC; von Schweinitz D; Kappler R; Muñoz M
    J Hepatol; 2014 May; 60(5):985-94. PubMed ID: 24412605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-214 promotes cell meastasis and inhibites apoptosis of esophageal squamous cell carcinoma via PI3K/AKT/mTOR signaling pathway.
    Guanen Q; Junjie S; Baolin W; Chaoyang W; Yajuan Y; Jing L; Junpeng L; Gaili N; Zhongping W; Jun W
    Biomed Pharmacother; 2018 Sep; 105():350-361. PubMed ID: 29864623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RIT1 suppresses esophageal squamous cell carcinoma growth and metastasis and predicts good prognosis.
    Feng YF; Lei YY; Lu JB; Xi SY; Zhang Y; Huang QT; Wu QL; Wang F
    Cell Death Dis; 2018 Oct; 9(11):1085. PubMed ID: 30348939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SH2D4A inhibits esophageal squamous cell carcinoma progression through FAK/PI3K/AKT signaling pathway.
    Shi H; Luo J; Ye L; Duan C; Zhang M; Ran H; Li C; Wu Q; Shao Y
    Cell Signal; 2024 Feb; 114():110997. PubMed ID: 38043670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. XPD inhibits cell growth and invasion and enhances chemosensitivity in esophageal squamous cell carcinoma by regulating the PI3K/AKT signaling pathway.
    Jian J; Li S; Liu LZ; Zhen L; Yao L; Gan LH; Huang YQ; Fang N
    Int J Mol Med; 2020 Jul; 46(1):201-210. PubMed ID: 32377720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.